Phase II Study of Avelumab in Combination with Cetuximab As a Rechallenge Strategy in Pre-Treated RAS Wild Type Metastatic Colorectal Cancer Patients: CAVE (Cetuximab-Avelumab) Colon Erika Martinelli , Giulia Martini , Vincenzo Famiglietti , Teresa Troiani , Stefania Napolitano , Filippo Pietrantonio , Davide Ciardiello , Marinella Terminiello , Carola Borrelli , Pietro Paolo Vitiello , Filippo De Braud , Federica Morano , Antonio Avallone , Nicola Normanno , Anna Nappi , Evaristo Maiello , Tiziana Latiano , Alfredo Falcone , Chiara Cremolini , Daniele Rossini , Giuseppe Santabarbara , Carmine Pinto , Daniele Santini , Claudia Cardone , Nicoletta Zanaletti , Alessandra Di Liello , Daniela Renato , Lucia Esposito , Francesca Marrone , Fortunato Ciardiello Annals of oncology（2020）
Key words
Cetuximab, Metastatic Colorectal Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
